10x Insights
Loading account…
Companies / Health Care / Stryker Corporation
SYK

Stryker Corporation

Health CareSurgical & Medical InstrumentsS&P 500
Ticker SYKPORTAGE, MIFiscal year ends DecemberBook value per share $62.11Diluted shares 386.2M

Stryker Corporation (NYSE: SYK) develops and sells medical technologies in MedSurg, Neurotechnology and Orthopaedics to doctors, hospitals and other healthcare facilities worldwide. Its products include surgical equipment and navigation systems, endoscopic and communications systems, patient-handling and emergency… From the company’s description.

In fiscal 2025, Stryker Corporation reported revenue of $25.12B, up 11.2% from fiscal 2024, and net income of $3.25B. Its operating margin was 19.5%, and operations generated $5.04B in cash. Over the twelve months to Jun 30, 2026, revenue was $25.84B.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$25.12BFY2025
+11.2% year over year
Last 12 mo $25.84B
19.47%FY2025
+3.1 percentage points
Last 12 mo 21.42%
$3.25BFY2025
+8.5% year over year
Last 12 mo $3.73B
15.02%FY2025
−3.5 percentage points
Last 12 mo 15.55%
Cash & financing
$5.04BFY2025
+18.9% year over year
Last 12 mo $5.53B
$4.28BFY2025
+22.8% year over year
Last 12 mo $4.70B
0.71FY2025
Was 0.66× a year earlier
Last 12 mo 0.62
386.5MFY2025
+0.2% year over year
Last 12 mo 386.2M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Stryker Corporation does

In the company’s own words

Stryker Corporation (NYSE: SYK) develops and sells medical technologies in MedSurg, Neurotechnology and Orthopaedics to doctors, hospitals and other healthcare facilities worldwide. Its products include surgical equipment and navigation systems, endoscopic and communications systems, patient-handling and emergency medical equipment, intensive-care products, clinical communication and virtual-care technology, devices for stroke and other vascular conditions, cranial surgery products, and implants for joint replacement, trauma and extremity procedures. Its Mako SmartRobotics platform supports robotic-assisted orthopaedic surgery. Stryker reports two segments: MedSurg and Neurotechnology, which generated 62% of 2025 net sales, and Orthopaedics, which generated 38%. The company sells in approximately 61 countries through subsidiaries, branches, dealers and distributors. Net sales were $25.1 billion in 2025, and it had approximately 56,000 employees globally at year-end. Founded in 1941 by orthopaedic surgeon and inventor Homer H. Stryker, the company was incorporated in Michigan in 1946 as the successor to his business. Its website is www.stryker.com.

Company details
Sector
Health Care
Industry (SIC)
Surgical & Medical Instruments
Headquarters
PORTAGE, MI
Fiscal year end
December
CIK
310764
SIC
3841

Financial performance, year by year

Fiscal 2013–2025 · USD
$-2.58B$5.17B$12.92B$20.67B$28.42B2013201420152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Stryker Corporation — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

979
funds hold it
1 of 35
superinvestors hold it
$31.59B
held by funds, at market
26.3%
of shares held by funds
20
bond issues held by funds

Superinvestors in Stryker Corporation · what they did last quarter

Terry SmithDECREASED -4.8%
Fundsmith
6.7%of 13F portfolio

Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.

Largest fund holders · Stryker Corporation’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.15%of fund net assets
VANGUARD 500 INDEX FUND
VOO · VANGUARD INDEX FUNDS
0.17%of fund net assets
iShares Core S&P 500 ETF
IVV · iShares Trust
0.17%of fund net assets
Fidelity 500 Index Fund
FXAIX · Fidelity Concord Street Trust
0.16%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Stryker Corporation’s bonds, as funds hold them

Funds report holding 20 issues of Stryker Corporation’s debt, $1.45B at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.17%, maturing 2027 to 2050.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Stryker Corporation and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Stryker Corporation's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Stryker Corporation's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.